A detailed history of Ubs Oconnor LLC transactions in Veru Inc. stock. As of the latest transaction made, Ubs Oconnor LLC holds 329,861 shares of VERU stock, worth $207,812. This represents 0.02% of its overall portfolio holdings.

Number of Shares
329,861
Holding current value
$207,812
% of portfolio
0.02%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$0.77 - $1.04 $23,592 - $31,865
30,640 Added 10.24%
329,861 $253,000
Q1 2024

May 15, 2024

SELL
$0.37 - $0.72 $148,288 - $288,560
-400,779 Reduced 57.25%
299,221 $209,000
Q4 2023

Feb 14, 2024

BUY
$0.67 - $1.17 $469,000 - $819,000
700,000 New
700,000 $504,000
Q1 2019

May 13, 2019

SELL
$1.2 - $1.59 $105,482 - $139,764
-87,902 Reduced 22.56%
301,704 $0
Q4 2018

Feb 15, 2019

SELL
$1.21 - $1.54 $3,323 - $4,230
-2,747 Reduced 0.7%
389,606 $545,000
Q3 2018

Nov 14, 2018

BUY
$1.38 - $2.27 $541,447 - $890,641
392,353 New
392,353 $0

Others Institutions Holding VERU

About VERU INC.


  • Ticker VERU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 80,146,704
  • Market Cap $50.5M
  • Description
  • Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N....
More about VERU
Track This Portfolio

Track Ubs Oconnor LLC Portfolio

Follow Ubs Oconnor LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Oconnor LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Oconnor LLC with notifications on news.